Katharina Nickel

Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease

Xiang Zhou, Patricia Flüchter, Katharina Nickel et al. · Cancers · 2020 · 43 citations · Full text

Medicine, Oncology, Pharmacology +13

Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes

Maximilian Steinhardt, Eliza Wiercinska, Manh Van Pham et al. · Journal of Translational Medicine · 2020 · 40 citations · Full text

Life Sciences, Hematology, Immunology +13

sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study

Thomas Wimmer, Raphael Mattes, Hans‐Joachim Stemmler et al. · Blood Advances · 2022 · 21 citations · Full text

Life Sciences, Hematology, Immunology +12

Cost-effectiveness of a fixed combination of netupitant and palonosetron (NEPA) relative to aprepitant plus granisetron (APR + GRAN) for prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a trial-based analysis

Marc Botteman, Katharina Nickel, Shelby Corman et al. · Supportive Care in Cancer · 2019 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17

Multiagent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone, and daratumumab (“Pom‐PAD‐Dara”) in relapsed/refractory multiple myeloma

Xiang Zhou, Maximilian Steinhardt, Denise Grathwohl et al. · Cancer Medicine · 2020 · 15 citations · Full text

Medicine, Oncology, Pharmacotherapy +16